Abstract The present study was designed to identify the source and kinetics of an alternatively spliced "embryonic" cellular fibronectin EIIIA (cFn-EIIIA) in relation to regenerating renal tubules in uranyl acetate (UA)-induced acute renal failure (ARF) in rats. Damage of the proximal tubules was found as early as day 2 after induction of ARF, peaked at day 5, and was almost substituted by epithelial relining by day 7. Immunohistochemistry showed de novo deposition of cFn-EIIIA in peritubular regions as early as day 2, then on the tubular basement membrane (TBM) after day 4. b1 Integrin, the receptor for Fn, was mainly found at the basal side of tubules in the normal control and increased in the interstitium after induction of ARF, but the staining pattern gradually returned to the control after day 7. Immunoelectron microscopy revealed that cFn-EIIIA was produced initially by the peritubular endothelium and later by fibroblastic cells and was deposited to the TBM, on which regenerating tubules proliferated, probably with cFn-EIIIA production. b1 Integrin was expressed in cFn-EIIIA-producing cells, especially in regenerating tubular cells, suggesting that cFn-EIIIA signal transduction affects regenerating tubules. Transforming growth factor (TGF)-b1 was found in some damaged proximal tubules and interstitial cells after induction of ARF and later in the regenerating tubules. CFn-EIIIA and b1 integrin mRNA levels were upregulated as early as day 2. TGF-b1 mRNA level significantly increased after day 3, suggesting a modulatory role for TGF-b1 on cFn-EIIIA production, but not by day 2. Our data suggest that cFn-EIIIA production by the endothelium during the very early response to tubular injury and by fibroblastic cells and regenerating tubules may play an important role in the cellular recovery of UA-induced ARF in rats.
Introduction
The importance of extracellular matrix (ECM) deposition in wound healing is well known [12] . Fibronectin (Fn) deposition seems to be essential in ECM, because it influences various cellular processes, including cell migration, proliferation, and synthesis of ECM in remodeling after injury [1, 5, 33] . Integrins serve as Fn receptors at the cell surface, and the interaction of Fn and integrins is crucial for Fns to exhibit the aforementioned cellular activities [13, 20] . Thus, it is conceivable that Fn deposition and cells expressing Fn receptors may be closely involved in the wound-healing process.
Fns are dimeric glycoproteins present in the plasma (plasma fibronectin; pFn) [29] and in tissue ECMs (cellular fibronectin; cFn) [23] . Both forms of Fn are encoded by a single gene and arise from a primary transcript by alternative RNA splicing at three distinct regions termed EIIIA, EIIIB, and V in rats [25, 30] . The equivalent regions in humans are designated EDA, EDB, and IIICS, respectively [16, 21, 35] . EIIIA and EIIIB domains are either completely included or excluded within the mature molecule of cFn [7, 17] . PFn, which is produced only by hepatocytes and circulates as a soluble protein, lacks both domains [29] . Splice variants containing EIIIA are expressed during development but are minimally present in normal adult tissue [2] . CFn-EIIIA may reappear, however, in the setting of epithelial repair [7] . In fact, de novo expression of cFn-EIIIA has been reported to play an important role in epithelial repair of the skin, liver, and lung [14, 19, 26] .
Barnes et al. [2] reported that the expression of cFn-EIIIA in the kidney parallels that of a-smooth muscle actin (a-SMA, myofibroblast phenotype) in several settings of renal remodeling, including embryonic, maturation, and diseased kidney. Cellular recovery after acute renal failure (ARF) is a unique form of wound healing or tissue remodeling, and Fn expression was reported in this process in association with regeneration of proximal tubules (PT) in post-ischemic ARF [4, 34] . Recently, Zuk et al. [36] documented that both pFn and cFns containing the V95 and/or EIIIA regions may contribute to the pathogenesis of ARF and to the repair seen in the postischemic rat kidney. However, the source of cFns and their precise relationship to the regeneration of tubular cells are not clear at present. We recently reported that interstitial cellular response, including transient appearance of myofibroblasts and macrophage infiltration, might be important for regenerative repair of PT in uranyl acetate (UA)-induced ARF in rats [27, 28] . However, whether the interstitial cellular response, which is probably important for wound healing, is also associated with cFn-EIIIA deposition as in other disease conditions or wound healing remains to be confirmed.
In the present study, we investigated the expression and source of cFn-EIIIA as well as of b1 integrin (as Fn receptor) during renal tubular damage and repair in UAinduced ARF in rats.
Materials and methods

Induction of UA-induced ARF
Experiments were conducted on 45 male Sprague-Dawley rats weighing 220-280 g (SLC Co., Shizuoka, Japan). Rats had free access to standard rat chow and drinking water. They received a single intravenous injection of 5 mg/kg of UA via the dorsal penile vein, and five rats were sacrificed before and at 2, 3, 4, 5, 7, 9, 15, and 21 days after UA injection. Rats were anesthetized with intraperitoneal pentobarbital sodium (30 mg/kg) and a blood sample was collected through the abdominal aorta, then both kidneys were removed after flushing with phosphate-buffered saline (PBS). Serum creatinine level was measured by the enzymatic method (Mizuho Med., Saga, Japan).
Tissue processing
The harvested kidneys were bisected through the longitudinal axis and some were cut into smaller sections. They were fixed with 20% neutral-buffered formalin, 4% paraformaldehyde or methacarn solution, then embedded in paraffin. Portions of renal tissues were snap frozen in cold N-hexane and stored at 70C for immunofluorescence (IF) studies. For pre-embedding for immunoelectron microscopy and immunohistochemistry, the renal tissues were fixed with 4% paraformaldehyde for 9 h and cryoprotected in 10%, 15% and 20% sucrose for 4 h each. The tissues were then placed in cryogenic embedding medium (OCT Compound, Sakura Finetechnical Co., Japan) and snap frozen in cooled N-hexane.
Histochemistry and immunohistochemistry
For histological examination, 4-mm-thick paraffin sections were stained with periodic acid-Schiff (PAS). To detect transforming growth factor (TGF)-b1, ED-1, as a marker of rat monocytes/ macrophages, and a-SMA, as a phenotypic marker of myofibroblasts, paraffin sections were first incubated with normal serum matched to the species for secondary antibodies. To detect cFn-EIIIA, 4% paraformaldehyde-fixed cryostat sections were used. After incubation with the primary antibodies (rabbit polyclonal antibody against TGF-b1; anti-LC; a generous gift from Dr. K.C. Flanders, NIH, USA [8] , mouse monoclonal anti-ED-1; Serotec, Oxford, UK, mouse monoclonal anti-human a-SMA; Dako, Carpinteria, CA, and mouse anti-cFn EDA, from human fibrosarcoma cells, this antibody cross-reacts with the rat EIIIA region; Chemicon International Inc., Temecula, CA), sections were reacted with biotin conjugated donkey anti-rabbit IgG (Chemicon) or donkey anti-mouse 1gG (Chemicon) for 30 min at room temperature. Then, streptavidin-conjugated peroxidase (Nichirei, Tokyo, Japan) was added for 30 min. After washing in PBS, the reaction products were visualized by incubation with diaminobenzidine detection kit (Nichirei). Histological controls were obtained by omitting the primary antibodies or replacing the primary antibodies with normal mouse or rabbit IgG at equivalent concentrations. No significant staining was observed in either normal control or experimental sections.
Cationic gold staining
Anionic sites (mainly representing sulfated glycosaminoglycans, the major constituents of the ECM) were visualized with a goldconjugated poly-l-lysine probe [15] . Deparaffinized sections were rinsed in PBS (pH 2.0) for 10 min, then incubated on a drop of cationic (poly-l-lysine) colloidal gold (5 nm) (diluted 1:100 in PBS at pH 2.0; Biocell Rescarch Laboratories, Cardiff, UK) for 4 h at 37C. The sections were washed in distilled water and developed with a silver enhancer (Biocell) for 10 min at room temperature.
Immunofluorescence studies IF studies were performed on 4-mm-thick cryostat sections fixed in cold acetone. Indirect IF was performed with rabbit anti-rat pFn antibody (from rat plasma; Chemicon), mouse anti-cFn EDA antibody (Chemicon), rabbit anti-pan-laminin antibody (from EHSmouse sarcoma; Sanbio, Netherlands), rabbit anti-collagen type-III antibody (from rat skin; Chemicon), rabbit anti-collagen type-IV antibody (from EHS-mouse sarcoma; LSL Co., Japan), or rabbit anti-b1 integrin antibody (a gift from Dr. K. Loester [18] ), then followed by fluorescein isothiocyanate-Iabeled swine anti-mouse IgG (Dako) or swine anti-rabbit IgG (Dako). Liver tissues were also examined by IF for cFn-EIIIA.
Immunoelectron microscopy
For ultrastructural localization of cFn-EIIIA or b1 integrin, 4% paraformaldehyde-fixed 6-to 8-mm cryostat sections were rinsed in 10% sucrose in PBS and then incubated with 10% normal donkey serum for 20 min, followed by incubation with the primary antibodies (mouse anti-cFn EDA or rabbit anti-b1 integrin). Following extensive washing in 10% sucrose-PBS, the sections were incubated with biotinylated donkey anti-mouse IgG (Chemicon) or antirabbit IgG (Fab')2 (Chemicon) for 60 min. After the sections had been fixed in 2% glutaraldehyde for 10 min, reaction products were visualized by incubating with diaminobenzidine, then the sections were examined post-fixed in 1% osmium tetroxide for 1 h, dehydrated in graded ethanol series, and embedded in Epon 812. Ultrathin sections were stained with lead citrate for 1.5 min, and examined with a JEM-1220 electron microscope (JEOL, Tokyo).
Enumeration of PT cells and ED-1-positive monocyte/macrophages
To determine the number of PT cells, reflecting a balance of tubular cell death and tubular cell proliferation, we counted the number of epithelial cells in 100 cross-sections of the PT in the outer stripe of outer medulla (OSOM) using PAS-stained sections and calculated the number of cells per field at 400 magnification. To minimize observer bias, morphometric examination was performed without the knowledge of the group from which the tissue was obtained.
The number of ED-1-positive cells was counted in 50 randomly selected fields in OSOM in each kidney at 400 magnification. The mean number at each time point was displayed in histograms.
Semiquantitative reverse transcription-polymerase chain reaction for cFn EIIIA, b1 integrin, and TGF-b1 mRNAs Total RNAs were isolated from frozen kidney tissues containing cortex and outer medulla by the acid guanidinium isothiocyanatephenol-chloroform extraction method [6] . Reverse transcription (RT) of RNA was performed using a first-strand cDNA synthesis kit (Boehringer Mannheim Co., Indianapolis, IN) with 1 mg total RNA. After completion of cDNA synthesis, RT enzyme was heat inactivated for 5 min at 99C. The polymerase chain reaction (PCR) reaction with Ampli Taq Gold (Applied Biosystems, Foster City, CA) was carried out for analysis of cFn-EIIIA, b1 integrin, and TGF-b1 mRNAs using primers described previously [11, 14, 31] . with an amplified RT-PCR product of 515 bp. Cycles were: 1 min denaturation at 94C, 30 s annealing at 45C for cFn-EIIIA, 1 min annealing at 56C for b1-integrin, 1 min annealing at 58C for TGF-b1, 1 min annealing at 60C for GAPDH and 1 min extension at 72C using Zymoreactor II (ATTO Co., Tokyo). PCR products were electrophoresed and the density of each DNA band was measured with NIH Image (Bethesda, MD). The mRNA levels for cFn-EIIIA, b1 integrin, and TGF-b1 were expressed as a ratio of the optical density units relative to GAPDH. Each RNA aliquot was amplified in duplicate.
Statistical analysis
Data are expressed as mean € standard error of the mean. Differences between data sets were determined using one-way analysis of variance followed by Fisher's t-test. A P level <0.05 was accepted as statistically significant. All statistical analyses were performed using StatView 4.02 software program for Macintosh.
Results
Serum creatinine
Serum creatinine increased significantly as early as day 3 after UA injection (P<0.01 vs baseline), reached a peak value at day 7 (P<0.01 vs baseline), then returned to normal level by day 15 ( Fig. 1 ).
PT cell damage and recovery
Histological changes in PT were assessed in PAS stained sections. As described in our previous report [24, 27] , the initial lesions of severe PT necrosis were predominantly located around the corticomedullary junction, where the denuded tubular basement membrane (TBM) was evident as early as day 2 (data not shown). Between day 4 and day 5, tubular necrosis was maximal and almost distributed in OSOM and cortex ( Fig. 2A) , and by day 7 denuded TBM was almost covered with regenerating cells of flattened cytoplasm (Fig. 2B ). The number of PT cells per cross-section significantly decreased at day 2 and progressively decreased by day 5, then increased over the baseline level and reached a peak level at day 7, but gradually returned to the normal control level by day 21 (Fig. 3 ).
ECM components
Positive immunostaining of three major ECM components-type-IV collagen, pan-laminin, and sulfated proteoglycan-was detected along the TBM in normal rats.
Immunostaining patterns of type-IV collagen and panlaminin did not change after the induction of ARF except for moderate staining in the focally expanded interstitium and around the dilated tubules (Fig. 4A , B, C, D). However, strong staining for sulfated proteoglycan, as evaluated by colloidal gold stainable anionic sites, was Staining intensity of sulfated proteoglycan judged by cationic gold staining in some peritubular areas (arrows) was stronger at day 7 (F) than that before induction of acute renal failure (E) stripe of outer medulla could be found. After day 4 (E), cFn-EIIIA staining on the tubular basement membrane (TBM) (arrowheads) was also noted and staining intensity was increased and was still present at day 15 (F). Immunostaining of pFn was weak along TBM and moderate in the peritubular regions in normal kidney (G), and the staining intensity was slightly increased at day 7 (H). A, B Arrows, border between cortex and OSOM; arrowheads, border between OSOM and inner stripe of outer medulla found in the peritubular areas after day 7 (Fig. 4E, F) . Positive immunostaining of type-III collagen as one of the interstitial collagens was found slightly in the peritubular region in normal rats; however, it did not change after induction of ARF (Fig. 4G, H) . Immunoreactive cFn-EIIIA was not detected in the interstitium of normal rats except in glomeruli and vascular walls (Fig. 5A, C) . However, immunoreactive cFn-EIIIA appeared mainly in the peritubular regions throughout the OSOM as early as day 2 (Fig. 5B, D) , and both peritubular and TBM staining patterns could be seen after 4 days (Fig. 5E ), suggesting that tubular epithelial cells may also produce cFn-EIIIA. The intensity of immunostaining of cFn-EIIIA was maintained until day 15, after then staining intensity on the TBM became weaker at day 21 (Fig. 5F ). In contrast to cFn-EIIIA, weak immunoreactivity for pFn was found along the TBM and in the peritubular regions in normal rats, and the staining pattern of pFn did not change after induction of ARF, but the intensity of immunostaining increased transiently between day 3 and day 7 (Fig. 5G, H) .
We also examined cFn-EIIIA in the liver tissues, but immunoreactive cFn-EIIIA could not be found in normal rats and in rats with UA-induced ARF (data not shown).
Immunostaining of b1 integrin
In normal control kidneys, positive staining for b1 integrin was observed mainly in the basal side of tubule and less extensively in the peritubular region (Fig. 6A) . After induction of ARF, immunoreactive b1 integrin gradually increased in peritubular regions throughout the OSOM until day 5 (Fig. 6B, C) . Positive staining of b1 integrin began to return to the normal pattern at day 7 (Fig. 6D) . 
Infiltration of ED-1-positive interstitial macrophages
In kidneys of normal rats, ED-1-positive monocyte/ macrophages were found only occasionally in the interstitium (data not shown). With the appearance of PT damage after induction of ARF, interstitial ED-1-positive cells increased in the region of injury, then gradually disappeared after PT regeneration had almost completed (Fig. 7A ). Mainly at day 5 and day 7, ED-1-positive cells in the tubular lumen could be also found (Fig. 7A) . Quantitative analysis revealed that interstitial ED-1-positive cells in OSOM increased significantly as early as day 2, reached a peak level at day 5, then gradually decreased in number (Fig. 7B) .
Appearance of interstitial a-SMA-positive myofibroblasts
In normal control kidneys, a-SMA positive cells were not detected in the interstitial regions but were present on the vascular walls (data not shown). After induction of ARF, a-SMA positive myofibroblasts appeared exclusively around severely damaged tubules in OSOM as early as day 2 (Fig. 8A ) and increased throughout OSOM with the progression of tubular necrosis by day 7 (Fig. 8B) , then decreased after day 9. a-SMA positive cells remained in the interstitial regions around the dilated tubules after day 15, but the staining areas was small and limited to the focally expanded interstitium (Fig. 8C) .
Immunostaining of TGF-b1
In normal control kidneys, positive staining of TGF-b1 was constitutively observed in the distal nephron (Fig. 9A) . At day 2 after induction of ARF, TGF-b1 immunoreactivity was found in the injured PT cells (Fig. 9B) as well as in a small number of the interstitial cells around the damaged PT in OSOM. At day 5, positive staining of TGF-b1 was increasingly observed in the interstitial cells around the denuded TBM (Fig. 9C) and also appeared in the regenerating PT cells mainly after 7 days (Fig. 9D) . By day 15, positive staining of TGF-b1 in regenerating PT cells was constantly found, but at day 21, staining intensity was reduced to that found in the normal control (data not shown). When the primary antibody against TGF-b1 was replaced with anti-rabbit IgG, no significant staining was observed before induction of ARF (Fig. 9E ) and at day 5 or day 7 (Fig. 9F) .
Ultrastructural localization of cFn-EIIIA and b1 integrin
In kidneys of normal rats, immunoelectron microscopy revealed the lack of cFn-EIIIA in the interstitium. At 2 days after induction of ARF, cFn-EIIIA was identified mainly in the basement membrane of endothelial cells of peritubular capillaries throughout OSOM and around a restricted area of fibroblast-like cells (Fig. 10A) , indicat- B At day 5, cFn-EIIIA is found around the fibroblast-like cells (arrows) and less extensively around infiltrating leukocyte (double arrow) as well as on the TBM underneath the regenerating proximal tubules (PT) (arrowheads). C Note that cFn-EIIIApositive peritubular capillary basement membrane and TBM are not distinguishable at some parts (arrows), and that cFn-EIIIA is found at the basal membrane of the regenerating PT (arrowheads). D At day 7, cFn-EIIIA is still present on the TBM underneath the relatively mature PT (arrowheads). * Necrotic PT, ** brush-border, PT proximal tubules, En endothelium, F fibroblast-like cells, C peritubular capillaries, L infiltrating leukocytes. Scale bar 2.0 mm ing that the initial source of cFn-EIIIA is mainly derived from peritubular vessel endothelium. Peritubular endothelial expression of cFn-EIIIA was persistently seen throughout the experiment. From day 4 to day 7, cFn-EIIIA was found around fibroblast-like cells, but in small amounts around infiltrating leukocytes (Fig. 10B) . Some peritubular vessel endothelium as well as fibroblast likecells, which attached firmly to the TBM, may supply cFn-EIIIA to the TBM (Fig. 10B, C) . At day 5, cFN-EIIIA was found also along the TBM of regenerating PT and was clearly seen at the basal membrane of the regenerating PT (Fig. 10B, C) , indicating that not only interstitial cells but also regenerating PT did produce cFn-EIIIA. After day 7, reaction products of cFn-EIIIA were still present along TBM covered with relatively maturated PT cells as well as around fibroblast-like cells (Fig. 10D) .
A weak staining of reaction products for b1 integrin was found along the basal fold of PT as well as peritubular endothelial surface in normal rats (Fig. 11A) . After 2 days, reaction products of b1 integrin were increasingly found at peritubular endothelium and basal side of PT as well as fibroblast-like cells (Fig. 11B, C) . At day 5 and day 7, in addition to peritubular endothelial surface, reaction products of b1 integrin were weakly expressed throughout the entire surface of immature proliferating PT (Fig. 11D) . At day 7, b1 integrin expression was relatively restricted to the basal fold of relatively maturate PT with brush border and was found occasionally at lateral and/or apical membrane of PT cells (Fig. 11E) . After 9 days, expression of b1 integrin in PT cells was almost compatible with that in normal PT cells (data not shown).
Expression of cFn-EIIIA, b1 integrin and TGF-b1 mRNAs At day 2, the expression of cFn-EIIIA mRNA was about 3.5-fold that in normal control, then it gradually increased reaching a peak level at day 9 and remained upregulated until day 21 (Fig. 12A, B) . The expression of b1 integrin mRNA at day 2 was also about 1.6-fold that in normal control, reached a peak level at day 4 and tended to decrease by day 21 (Fig. 12A, C) . The expression of TGFb1 mRNA was first increased at day 3, continued to increase till day 15 and tended to decrease by day 21 (Fig. 12A, D) . Fig. 11 Immunoelectron micrographs for b1 integrin before (A) and at days 2 (B), 4 (C), 5 (D), and 7 (E) after induction of acute renal failure. A In normal kidney, reaction products indicative of b1 integrin are found mainly at the basal fold of the proximal tubules (PT). B At day 2, b1 integrin is found at the cell surface of some peritubular endothelium (arrows) as well as at the basal membrane of the PT (arrowheads). C At day 4, b1 integrin is found at the cell surface of peritubular endothelium and fibroblast-like cell, but less extensively at the cell surface of leukocytes. D At day 5, staining for b1 integrin is weak around the whole surface of immature regenerating PT. E At day 7, staining for b1 integrin is almost restricted to the basal mernbrane and basal fold of the relatively matured PT with brush-border (arrowheads) and confined residually at the cell surface of the lateral and/or apical membrane (arrows). * necrotic PT, ** brush-border, PT proximal tubules, En endothelium, F fibroblast-like cells, L infiltratincy leukocyte. Scale bar 2.0 mm
Discussion
The process of cellular recovery from ARF occurs through an orchestrated series of events, whereby dedifferentiated PT cells proliferate and/or migrate onto the denuded TBM to establish a new, differentiated epithelium [32] . To complete these processes of cellular recovery, synthesis of new ECM and reformation of cell-cell contacts must take place. In the present study, we found that of ECM components examined here, including pan-laminin, sulfated proteoglycan, collagen types III and IV, pFn, and cFn-EIIIA, only cFn-EIIIA newly appeared and then deposited in the peritubular regions before and during the PT regeneration.
As reported previously [27, 28] and here in this model, a-SMA-positive myofibroblasts transiently appeared just around the TBM of damaged PT and they often intervened between the basement membrane of the peritubular capillary and TBM until PT regeneration had completed. Interstitial myofibroblasts may be derived from the resident interstitial fibroblast-like cells [27] . In this model, cFn-EIIIA was mainly produced by the peritubular endothelium and the fibroblast-like cells (myofibroblasts) located very close to the TBM and may be furnished to the denuded TBM, on which the regenerating PT cells proliferated and/or migrated. In addition, we found cFn-EIIIA at the basal membrane of the regenerating PT cells, suggesting production of cFn-EIIIA by the regenerating PT.
Walker [34] demonstrated enhanced immunostaining of Fn during renal tubular regeneration after ischemic ARF in rats. Furthermore, Basile et al. [4] reported that the specific increase in cFn-EIIIA mRNA in regenerating PT correlated closely with the deposition of Fn-EIIIA protein in the TBM of regenerating PT. Recently, Zuk et al. [36] documented that both pFn and cFns containing V95 and/or EIIIA regions may contribute to the damage and repair in an ischemia model of ARF in rats. Though the ARF model is different, our data extended the findings of previous reports [4, 34, 36] by demonstrating the source and the location of cFn-EIIIA and its association with the regenerating PT cells.
CFn-EIIIA mRNA is abundantly expressed during embryogenesis and wound healing compared with normal adult tissue [2] . CFn-EIIIA may reappear, however, in the setting of epithelial repair and has been reported to play an important role in epithelial repair of the skin, liver, and lung [14, 19, 26] . Barnes et al. [2] reported that the expression of cFn-EIIIA in the kidney follows that of a-SMA (myofibroblast phenotype) in several settings of renal remodeling, including embryonic, maturation, and diseased kidney. Cellular recovery after ARF is a unique form of wound healing or tissue remodeling. Therefore, based on the known biological properties of cFn-EIIIA mentioned so far, our findings suggest that upregulation of cFn-EIIIA mRNA and deposition of cFn-EIIIA beneath the basal side of regenerating PT cells (on the TBM) before and during the cellular recovery after ARF may be necessary for proliferation, migration, and/or even differentiation of PT cells.
b1 Integrin, containing the non-covalently associated common b1 subunit and several types of a subunits, functions primarily as a cell surface receptor for ECM molecules such as Fn, collagen, laminin, and vitronectin and mainly mediates the interaction between cells and ECM. It also plays critical roles in ECM synthesis, ECM assembly, proliferation, and differentiation of cells, thereby contributing to embryonic development, tissue homeostasis, and wound healing [13, 20, 22] . In the present study, b1 integrin mRNA was upregulated during damage and repair processes in rats with ARF, and b1 integrin protein increased in cells known to produce cFn-EIIIA, such as peritubular endothelial cells and interstitial cells, indicating that cFn is functional within these cells. Importantly, since the basal rnembrane of regenerating PT expressed b1 integrin, cFn-EIIIA on the TBM should affect cellular activity of the regenerating PT cells via paracrine and/or autocrine fashion and should contribute to cellular recovery from ARF.
The underlying pathomechanisms resulting in marked production of cFn-EIIIA by peritubular endothelium throughout OSOM during the early period of PT injury are poorly understood. We examined the source of TGFb1 protein, which is one of the major cytokines that stimulate the production of cFn-EIIIA [10] . At day 2, when cFn-EIIIA was already expressed in the peritubular endothelium, TGF-b1 mRNA was not increased and TGF-b1 protein was found only in a few damaged PT cells but not in interstitial cells, suggesting that TGF-b 1 is probably not the initial stimulant of cFn-EIIIA expression in the peritubular endothelium. However, TGF-b1 might be released by platelets in the peritubular capillaries before day 2. Moreover, it is also possible that alterations of metabolic exchange between tubules and peritubular capillaries already exist, leading to the activation of peritubular endothelium to produce cFn-EIIIA. Since hepatic capillary endothelial cells did not express cFn-EIIIA during the experiment, it is unlikely that UA directly stimulated peritubular endothelium to produce cFn-EIIIA.
In our study, the expression of cFn-EIIIA in the peritubular endothelium preceded the appearance of peritubular myofibroblasts, suggesting that, in addition to TGF-b1 released by damaged PT, cFn-EIIIA might induce a-SMA expression (myofibroblastic phenotype) on fibroblast-like cells as reported by George et al. [10] . These investigators showed that hepatic stellate cells transdifferentiate to myofibroblast-like cells by cFn-EIIIA from sinusoidal endothelial cells following hepatic injury. In this model, the mechanisms of disappearance of myofibroblasts are not known and peritubular endothelium and regenerated PT may be the main sources of cFn-EIIIA after day 15, when almost all a-SMA-positive myofibroblasts disappear.
Basile et al. [3, 4] demonstrated a rapid and prolonged expression of TGF-b1 mRNA and peptide primarily in regenerating PT in ischemic ARF in rats [3] and the role of TGF-b1 in stimulating ECM synthesis, including cFn-EIIIA, during renal recovery [4] . In our study, we also found TGF-b1 protein in regenerating PT associated closely with cFn-EIIIA deposition on the proximal TBM. However, in contrast to the ischemia ARF model, TGF-b1 expression was also found in interstitial cells in our model. In the present study, the cells that produced TGFb1 in the interstitium were not identified, but it is possible that both myofibroblasts and macrophages, as judged by the peritubular location of TGF-b1 stainable cells, can produce TGF-b1, resulting in stimulating cFn-EIIIA production among myofibroblasts, macrophages, and regenerating PT cells. While macrophages producing TGF-b1 may be one of the key elements in renal fibrosis [9] , in our model, infiltration of macrophages was transient, so that the effect of TGF-b1 released by these macrophages on myofibroblasts must be limited, resulting in almost no production of interstitial collagen type III, a marker for renal fibrosis as shown in this study. Regulation of ECM production, deposition, and degradation in our model remain largely unknown.
In conclusion, the peritubular endothelium and fibroblast-like cells may furnish cFn-EIIIA on the denuded TBM, on which the regenerating PT cells proliferate and/ or migrate, and regenerating PT cells per se also produce cFn-EIIIA, associated with expression of its receptor, b1 integrin, on the basal cell membrane. Based on the known biological properties of cFn-EIIIA, our data suggest that cFn-EIIIA may play an important role in the cellular recovery after UA-induced ARF in rats.
